Spire Healthcare Group (LON:SPI) Stock Price Down 20.1% – What’s Next?

Spire Healthcare Group plc (LON:SPI)’s share price traded down 20.1% on Thursday . The company traded as low as GBX 169 ($2.18) and last traded at GBX 179.39 ($2.31). 21,522,984 shares traded hands during trading, an increase of 2,011% from the average session volume of 1,019,659 shares. The stock had previously closed at GBX 224.50 ($2.89).

Spire Healthcare Group Stock Down 18.1 %

The firm has a market cap of £738.69 million, a price-to-earnings ratio of 26.18, a PEG ratio of 1.06 and a beta of 0.96. The company has a quick ratio of 0.74, a current ratio of 0.70 and a debt-to-equity ratio of 62.25. The firm has a fifty day moving average price of GBX 229.09 and a 200-day moving average price of GBX 230.72.

Spire Healthcare Group (LON:SPI) last issued its quarterly earnings results on Thursday, March 6th. The company reported GBX 8.80 ($0.11) earnings per share (EPS) for the quarter. Spire Healthcare Group had a return on equity of 3.82% and a net margin of 1.96%. As a group, sell-side analysts forecast that Spire Healthcare Group plc will post 15.6634747 EPS for the current year.

About Spire Healthcare Group

Spire Healthcare Group plc, together with its subsidiaries, owns and operates private hospitals and clinics. It offers various treatments in the areas of allergy and infectious diseases, blood tests, bones and joints, bowel treatments, breast screening and surgery, cancer investigations and treatments, cosmetic surgery, cyst removal, and dental surgery, as well as ear, nose, and throat treatments.